Thyroid hormone transporter genes and grey matter changes in patients with major depressive disorder and healthy controls

Psychoneuroendocrinology

Volumn 36, Issue 6, 2011, Pages 929-934

  Dixson, Luanna ^a   Ridler, Khanum ^a   Nichols, Thomas E ^a   Saemann, Philipp G ^b   Auer, Dorothee P ^b   Holsboer, Florian ^b   Muglia, Pierandrea ^c   Matthews, Paul M ^a,d   Inkster, Becky ^a,d  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c GSK   (Italy)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Grey matter volume; Magnetic resonance imaging; Major depressive disorder; Polymorphism; Thyroid hormone transporter genes; Voxel based morphometry

Indexed keywords

ANXIETY DISORDER; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; GENE; GENETIC ASSOCIATION; GENOTYPE; GERMANY; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MONOCARBOXYLATE TRANSPORTER 8 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PRIORITY JOURNAL; QUALITY CONTROL; RECURRENT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSTHYRETIN GENE; VOXEL BASED MORPHOMETRY;

ALLELES; ANXIETY DISORDERS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; HYDROCORTISONE; MAGNETIC RESONANCE IMAGING; MALE; MONOCARBOXYLIC ACID TRANSPORTERS; OCCIPITAL LOBE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREALBUMIN;

EID: 79956298063     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.12.002     Document Type: Article

References (31)

1. Avramides A., Papamargaritis K., Mavromatis I., Saddic G., Vyzantiadis A., Milonas I. Visual evoked potentials in hypothyroid and hyperthyroid patients before and after achievement of euthyroidism. J. Endocrinol. Invest. 1992, 15:749-753.
2. Bauer M., Goetz T., Glenn T., Whybrow P.C. The thyroid-brain interaction in thyroid disorders and mood disorders. J. Neuroendocrinol. 2008, 20:1101-1114.
3. Bahls S.C., Calvalho G.A. The relation between thyroid function and depression: a review. Rev. Bras. Psiquiatr. 2004, 26(Suppl 1):41-49.
4. Cuenco K.T., Friedland R., Baldwin C.T., Guo J., Vardarajan B., Lunetta K.L., Cupples L.A., Green R.C., Decarli C., Farrer L.A. Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families. Neurobiol. Aging 2009, 32:249-256.
5. Forkel S.J., de Schotten T.M., Dell'Acqua F., Catani M. An uniquely human pathways connects frontal and occipital lobes. British Chapter ISMRM, Proceedings of the Post-graduate Magnetic Resonance Symposium, Oral Presentation 2010, Abstract 01.
6. Fuchs O., Farr N.P., Pohlenz J., Schmidt H. Elevated serum triiodothyronine and intellectual and motor disability with paroxysmal dyskinesia caused by a monocarboxylate transporter 8 gene mutation. Dev. Med. Child. Neurol. 2009, 51:240-244.
7. Gillespie C.F., Nemeroff C.B. Hypercortisolemia and depression. Psychosom. Med. 2005, 67:26-28.
8. Guadano-Ferraz A., Benavides-Piccione R., Venero C., Lancha C., Vennstrom B., Sandi C., DeFelipe J., Bernal J. Lack of thyroid hormone receptor alpha1 is associated with selective alterations in behavior and hippocampal circuits. Mol. Psychiatry 2003, 8:30-38.
9. Hayasaka S., Phan K.L., Liberzon I., Worsley K.J., Nichols T.E. Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 2004, 22:676-687.
10. Howland R.H. Thyroid dysfunction in refractory depression: Implications for pathophysiology and treatment. J. Clin. Psychiatry 1993, 54:47-54.
11. Inkster B., Nichols T.E., Saemann P.G., Auer D.P., Holsboer F., Muglia P., Matthews P.M. Association of gsk3beta polymorphisms with brain structural changes in major depressive disorder. Arch. Gen. Psychiatry 2009, 66:721-728.
12. Koolschijn P.C., van Haren N.E., Lensvelt-Mulders G.J., Hulshoff Pol H.E., Kahn R.S. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum. Brain Mapp. 2009, 30:3719-3735.
13. Krausz Y., Freedman N., Lester H., Barkai G., Levin T., Bocher M., Chisin R., Lerer B., Bonne O. Brain spect study of common ground between hypothyroidism and depression. Int. J. Neuropsychopharmacol. 2007, 10:99-106.
14. Krausz Y., Freedman N., Lester H., Newman J.P., Barkai G., Bocher M., Chisin R., Bonne O. Regional cerebral blood flow in patients with mild hypothyroidism. J. Nucl. Med. 2004, 45:1712-1715.
15. Larsen R.P., Davies T.F., Schlumberger M.-J., Hay I.D. Thyroid physiology and diagnostic evaluation of patients with thyroid disorder. Williams Textbook of Endocrinology 2003, 331-373. Saunders, Philadelphia. R.P. Larson (Ed.).
16. Lazarus J.H. Lithium and thyroid. Best Pract. Res. Clin. Endocrinol. Metab. 2009, 23:723-733.
17. Lupien S.J., Leon M., Santi S., Convit A., Tarshish C., Nair N.P.V., Thakur M., McEwen B.S., Hauger R.L., Meaney M.J. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1998, 1:69-73.
18. Moore G.J., Bebchuk J.M., Wilds I.B., Chen G., Manji H.K. Lithium-induced increase in human brain grey matter. Lancet 2000, 356:1241-1242. (erratum).
19. Morreale de Escobar G., Obregon M.J., Escobar del Rey F. Role of thyroid hormone during early brain development. Eur. J. Endocrinol. 2004, 151(Suppl. 3):U25-U37.
20. Nagamachi S., Jinnouchi S., Nishii R., Ishida Y., Fujita S., Futami S., Kodama T., Tamura S., Kawai K. Cerebral blood flow abnormalities induced by transient hypothyroidism after thyroidectomy-analysis by tc-99m-hmpao and spm96. Ann. Nucl. Med. 2004, 18:469-477.
21. Rovet J.F., Simic N. The role of transient hypothyroxinemia of prematurity in development of visual abilities. Sem. Perinatol. 2008, 32:431-437.
22. Rovet J.F., Skocic J., Khan S. Grey matter reductions in children with congenital hypothyroidism, a voxel based morphometry (VBM study). American Thyroid Association 80th Annual Meeting, Oral Presentation 2009, Abstract 09.
23. Rush A.J. The varied clinical presentations of major depressive disorder. J. Clin. Psychiatry 2007, 68(Suppl. 8):4-10.
24. Schwartz C.E., Stevenson R.E. The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 2007, 21:307-321.
25. Schweizer U., Weitzel J.M., Schomburg L. Think globally: act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas. Mol. Cell. Endocrinol. 2008, 289:1-9.
26. Starkman M.N., Giordani B., Gebarski S.S., Berent S., Schork M.A., Schteingart D.E. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol. Psychiatry 1999, 46:1595-1602.
27. Tozzi F., Prokopenko I., Perry J.D., Kennedy J.L., McCarthy A.D., Holsboer F., Berrettini W., Middleton L.T., Chilcoat H.D., Muglia P. Family history of depression is associated with younger age of onset in patients with recurrent depression. Psychol. Med. 2008, 38:641-649.
28. Treadway M.T., Grant M.M., Ding Z., Hollon S.D., Gore J.C., Shelton R.C. Early adverse events, HPA activity and rostral anterior cingulate volume in MDD. PLoS One 2009, 4:4887.
29. van der Deure W.M., Appelhof B.C., Peeters R.P., Wiersinga W.M., Wekking E.M., Huyser J., Schene A.H., Tijssen J.G., Hoogendijk W.J., Visser T.J., Fliers E. Polymorphisms in the brain-specific thyroid hormone transporter oatp1c1 are associated with fatigue and depression in hypothyroid patients. Clin. Endocrinol. (Oxf.) 2008, 69:804-811.
30. Venero C., Guadano-Ferraz A., Herrero A.I., Nordstrom K., Manzano J., de Escobar G.M., Bernal J., Vennstrom B. Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor alpha1 can be ameliorated by T3 treatment. Genes Dev. 2005, 19:2152-2163.
31. Zoeller R.T., Rovet J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J. Neuroendocrinol. 2004, 101:809-818.